Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-16 9:29 pm Purchase | 2025-01-09 | 13D | Quanterix Corporation QTRX | Akoya Biosciences Inc. AKYA | 2,955,532 6.200% | 2,955,532 (New Position) | Filing History |
| 2025-01-16 6:00 pm Purchase | 2025-01-09 | 13D | Akoya Biosciences, Inc. AKYA | Quanterix Corp QTRX | 27,714,011 55.900% | 27,714,011 (New Position) | Filing History |
| 2024-11-04 07:39 am Purchase | 2024-09-30 | 13G | Akoya Biosciences, Inc. AKYA | Schindel Yair Chaim | 4,878,459 9.860% | 1,801,264 (+58.54%) | Filing History |
| 2024-08-28 10:45 am Purchase | 2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA | Blue Water Life Science Advisors LP | 4,697,785 9.560% | 4,697,785 (New Position) | Filing History |
| 2024-02-14 4:09 pm Purchase | 2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA | Telegraph Hill Partners III L.P. | 17,675,247 36.000% | 2,000,000 (+12.76%) | Filing History |
| 2024-02-12 09:11 am Purchase | 2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 3,517,360 7.200% | 800,000 (+29.44%) | Filing History |
| 2024-01-03 08:50 am Purchase | 2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA | Schindel Yair Chaim | 3,077,195 6.270% | 158,756 (+5.44%) | Filing History |
| 2023-06-13 07:18 am Purchase | 2023-06-12 | 13G | Akoya Biosciences, Inc. AKYA | Schindel Yair Chaim | 2,918,439 6.030% | 2,918,439 (New Position) | Filing History |
| 2023-02-15 09:15 am Unchanged | 2022-12-31 | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 2,717,360 7.200% | 0 (Unchanged) | Filing History |
| 2023-02-14 3:47 pm Sale | 2022-12-31 | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 2,717,360 7.200% | -96,411 (-3.43%) | Filing History |
| 2023-02-07 4:30 pm Sale | 2023-02-03 | 13D | Akoya Biosciences, Inc. AKYA | Hudson Executive Capital LP | 1,892,204 4.990% | -555,354 (-22.69%) | Filing History |
| 2022-12-02 4:15 pm Sale | 2022-11-30 | 13D | Akoya Biosciences, Inc. AKYA | Hudson Executive Capital LP | 2,447,558 6.400% | -1,250,000 (-33.81%) | Filing History |
| 2022-09-13 4:10 pm Purchase | 2022-09-09 | 13D | Akoya Biosciences, Inc. AKYA | Hudson Executive Capital LP | 3,697,558 9.800% | 1,617,015 (+77.72%) | Filing History |
| 2022-02-25 10:57 am Purchase | 2021-12-31 | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 2,813,771 7.600% | 2,813,771 (New Position) | Filing History |
| 2022-02-14 4:44 pm Unchanged | 2021-12-31 | 13G | Akoya Biosciences, Inc. AKYA | Telegraph Hill Partners III L.P. | 15,675,247 42.100% | 0 (Unchanged) | Filing History |
| 2021-10-18 4:02 pm Purchase | 2021-10-06 | 13D | Akoya Biosciences, Inc. AKYA | Hudson Executive Capital LP | 2,080,543 5.600% | 2,080,543 (New Position) | Filing History |
| 2021-05-28 4:01 pm Purchase | 2021-04-20 | 13G | Akoya Biosciences, Inc. AKYA | Telegraph Hill Partners III L.P. | 15,675,247 42.700% | 15,675,247 (New Position) | Filing History |